🟢 EIQ.XA is trading 31.7% up today on U.S. leadership hires to accelerate FDA progress

EIQ.XA is trading 31.7% up at A$1.63 after announcing new U.S.-focused leadership hires aimed at accelerating FDA regulatory progress and commercial expansion.

• The company has appointed Matthew Dodds as CFO and added senior clinical leadership to support growth plans for its cardiovascular AI platform.
• The move signals an aggressive push toward U.S. commercialization and FDA clearance, which the market is treating as a major strategic milestone.